- $1.17bn
- $5.23bn
- $2.13bn
- 66
- 82
- 23
- 58
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,231 | 1,403 | 1,580 | 1,961 | 2,126 |
Cost of Revenue | |||||
Gross Profit | 442 | 592 | 723 | 842 | 1,030 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,388 | 1,071 | 1,191 | 1,649 | 1,595 |
Operating Profit | -157 | 332 | 388 | 312 | 531 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -410 | -153 | -8.14 | -544 | -1,881 |
Provision for Income Taxes | |||||
Net Income After Taxes | -423 | -323 | -26.1 | -469 | -1,988 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -423 | -322 | -25.8 | -459 | -1,977 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -423 | -322 | -25.8 | -459 | -1,977 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.24 | -0.928 | 0.019 | -1.26 | -5.76 |
Dividends per Share |